Detection of Leishmania in Unaffected Mucosal Tissues of Patients with Cutaneous Leishmaniasis Caused by Leishmania (Viannia) Species
|
|
- Job Knight
- 6 years ago
- Views:
Transcription
1 MAJOR ARTICLE Detection of Leishmania in Unaffected Mucosal Tissues of Patients with Cutaneous Leishmaniasis Caused by Leishmania (Viannia) Species Roger Adrian Figueroa, Leyder Elena Lozano, Ibeth Cristina Romero, Maria Teresa Cardona, Martin Prager, Robinson Pacheco, Yira Rosalba Diaz, Jair Alexander Tellez, and Nancy Gore Saravia Centro Internacional de Entrenamiento e Investigaciones Médicas, Cali, Colombia Background. Leishmania (Viannia) species are the principal cause of mucosal leishmaniasis. The natural history and pathogenesis of mucosal disease are enigmatic. Parasitological evaluation of mucosal tissues has been constrained by the invasiveness of conventional sampling methods. Methods. We evaluated the presence ofleishmania in the mucosa of 26 patients with cutaneous leishmaniasis and 2 patients with mucocutaneous leishmaniasis. Swab samples of the nasal mucosa, tonsils, and conjunctiva were analyzed using polymerase chain reaction with LV-B1 primers and Southern blot hybridization. Results. Two patients with mucocutaneous leishmaniasis and 21 (81%) of 26 patients with cutaneous leishmaniasis had Leishmania kinetoplast minicircle DNA (kdna) in mucosal tissues. kdna was amplified from swab samples of nasal mucosa from 14 (58%) of 24 patients, tonsils from 13 (46%) of 28 patients, and conjunctiva from 6 (25%) of 24 patients. kdna was detected in the mucosa of patients with cutaneous disease caused by Leishmania panamensis, Leishmania guyanensis, and Leishmania braziliensis. Conclusion. The asymptomatic presence of parasites in mucosal tissues may be common in patients with Leishmania (Viannia) infection. Although mucosal involvement has been occasionally described in human infection due to a broad range of Leishmania species [1 5], the risk of mucosal leishmaniasis is a constant concern in infection due to Leishmania of theviannia subgenus [6, 7]. Lymphatic [8 9] or hematogenous [10, 11] metastasis of parasites from the cutaneous site of inoculation to the nasopharyngeal mucosa is considered to be the underlying cause of mucosal disease [12]. However, the dissemination Received 13 November 2008; accepted 7 March 2009; electronically published 1 July Potential conflicts of interest: none reported. Financial support: Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnología Francisco José de Caldas (Young Investigators Program awards to R.A.F. and M.T.C., grants and ; and grant to L.E.L. and J.A.T.); United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases ICDR (U19 AI to N.G.S.); Fogarty International Center (NIH) (grant D43 TW to N.G.S.). Reprints or correspondence: Nancy Gore Saravia, Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Carrera 125 #19-225, A.A. 5390, Cali, Colombia (saravian@cideim.org.co). The Journal of Infectious Diseases 2009; 200: by the Infectious Diseases Society of America. All rights reserved /2009/ $15.00 DOI: / of Leishmania to the nasopharyngeal mucosa and the pathogenesis of mucosal leishmaniasis are poorly understood. Systematic otorhinolaryngological evaluation can reveal early mucosal involvement. The frequency of early symptomatic mucosal disease has been described in 3% of cutaneous cases, which is similar to the prevalence of advanced mucosal leishmaniasis [13]. Nevertheless the early involvement of mucosa and indeed, the diagnosis of mucosal leishmaniasis, are constrained by the invasiveness and limited sensitivity of biopsy and histopathological methods, as well as by the fact that these methods require skilled medical specialists. The rationale for this exploratory study was twofold; we aimed to examine an alternative, less-invasive diagnostic approach for mucosal leishmaniasis and to establish proof-of-principle that swab samples combined with molecular amplification of kinetoplast minicircle DNA (kdna) could be an informative strategy that could aid in understanding the natural history of the dissemination of Leishmania (Viannia) infection to mucosal tissues in the human host. We have demon- 638 JID 2009:200 (15 August) Figueroa et al
2 strated the presence of Leishmania (Viannia) kdna in the unaffected mucosal sites of patients with active cutaneous or mucocutaneous disease using samples obtained with swabs and analyzed with polymerase chain reaction (PCR) of kdna and Southern blot hybridization. MATERIALS AND METHODS Study Population Patients consulting at Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM) clinics in Cali, Colombia, and in the level 1 health post La Independencia within the public health network of the municipality in Buenaventura Colombia, were invited to participate in this exploratory study. Inclusion criteria were all of the following: adult status (18 70 years of age), clinical and/or epidemiological history of exposure to transmission, 1 or more active lesions, parasitologic diagnosis, no receipt of prior antileishmanial drug treatment for current lesions, and voluntary participation after providing written informed consent. Pregnancy was an exclusion criterion because treatment is contraindicated for pregnant individuals. One patient (D1019) with mucosal disease who was 74 years old and had received antileishmanial treatment for 5 days was included with permission of the CIDEIM Institutional Review board for research involving human subjects. Twenty-eight patients with parasitologically confirmed active tegumentary leishmaniasis were included in the study after providing signed informed consent. The study protocol and sampling procedures were approved by the CIDEIM institutional review board for studies involving human subjects and conducted in compliance with national and international guidelines for the protection of human subjects from research risks. The study population included 26 patients who presented with cutaneous lesions only and 2 patients who presented with mucocutaneous leishmaniasis. Clinical Diagnosis All patients were evaluated by a physician with experience in the diagnosis and management of leishmaniasis. A complete medical history was obtained and a physical examination was performed by this physician before the inclusion of a patient in the study. During the review of systems, the patient was queried about signs and symptoms of mucosal involvement; these included nasal congestion, secretion, scab expulsion, nasal pruritus, epistaxis and mass sensation. Direct anterior rhinoscopy and mouth and palate examinations were performed for all patients to detect and evaluate mucosal involvement. Any patient reporting at least 1 symptom of mucosal involvement during the clinical history or with any evident abnormality in the mucosal evaluation was considered as a possible case of mucocutaneous leishmaniasis and was referred to an ear, nose, and throat specialist for evaluation. Mucosal biopsies were performed by this specialist. Laboratory Diagnosis Diagnosis of cutaneous lesions was performed by direct microscopic examination of tissue smears obtained from the lesion border and/or culture of tissue fluid aspirated with a tuberculin syringe from the lesion border [14]. Diagnosis of mucosal lesions was achieved by biopsy and histopathological examination [14]. Patients were enrolled in the study and swab samples obtained 1 4 weeks after the initial consultation and parasitological diagnosis. The mucosal areas that were evaluated by swabbing (except for lesions in patients with mucosal disease) were not manipulated or otherwise subjected to intervention at any time prior to obtaining swab samples. Patient demographic characteristics and the clinical characteristics of patients lesions are summarized in table 1. Parasite identification. Species were identified on the basis of the reactivity of the parasites with a panel of Viannia subgenus- and species-specific monoclonal antibodies and isoenzyme polymorphisms [15, 16]. Sampling. Swab samples of lesion tissue and the conjunctiva, nasal mucosa, and palatine tonsils were obtained from each patient using sterile swabs (BuccalAmp kit; Epicenter Biotechnologies) after parasitological diagnosis had been established. Biopsy samples of mucosal tissues were obtained only from the patients with mucosal lesions. To obtain nasal, tonsilar, and conjunctival swab samples, the nasal septum, tonsils, and the inner surface of the lower eyelid, respectively, were gently rubbed with the swab. Cutaneous lesion samples were obtained by swabbing the surface of an ulcerated lesion after thorough cleaning with 70% alcohol. All samples were stored in their original packaging at 20 C until processing. Sample processing. DNA extraction from lesion, conjunctival, and nasal swab samples was performed using the BuccalAmp kit and the protocol recommended by the manufacturer. Recovery of the parasite kdna was optimized by extraction of DNA with 350 ml of absolute ethanol and 40 ml of 3 mol/l sodium acetate and overnight refrigeration at 45 C. The extracted DNA was recovered by centrifugation at 16,100 g at 4 C for 15 min in an Eppendorf 5415C microcentrifuge, followed by resuspension in 500 ml of 70% ethanol and recentrifugation under the same conditions. The supernatant was discarded and the remaining liquid evaporated by drying in a thermal block at 60 C. Finally, DNA was resuspended in 50 ml of RNase- and DNase-free water. DNA was extracted from tonsil swab samples using the AllPrep DNA/ RNA Minikit (Qiagen) in accordance with the manufacturer s instructions. The following negative controls were included: extraction reagents; PCR reagents, and mucosal swabs from 2 Leishmania in Unaffected Mucosal Tissues JID 2009:200 (15 August) 639
3 Table 1. Summary of clinical and demographic characteristics and lesion characteristics of the patient with leishmaniasis included in the study. Patient code Age, years Lesions, no. Lesion type Lesion location Size, mm Lymphatic track Regional LAD Time of evolution, months Leishmania (Viannia) species recovered City and department of residence Primary infection D1002 D1003 D1005 D1006 D1007 D1008 D Ulcer Arm L. panamensis Cali, Papule Leg No No Ulcer Neck No No 1.5 L. panamensis Cali, Ulcer Arm 3 3 No No Ulcer Head 4 3 No No 3 L panamensis Roldanillo, Ulcer Head 3 x3 No No 2 Plaque Head ND No No Ulcer Neck L braziliensis Cali, Ulcer Head ND Granulomatous lesion Arm L. panamensis Jamundi, 21 1 Ulcer Head L. braziliensis Suarez, Cauca 22 4 Ulcer Leg No 4 L. guyanensis Guacari, Ulcer Leg No No 4 Ulcer Leg No 4 640
4 D1010 D1011 D1012 Ulcer Leg No No Ulcer Leg 10 6 No No 2 L. guyanensis Vijes, 23 3 Ulcer Arm 6 4 No No 2.5 L. panamensis Cali, Ulcer Leg 9 8 No No 2.5 Ulcer Leg No No Plaque Head No 1 L. panamensis Jamundi, Plaque Head 9 12 No 1 D1013 a 57 3 Ulcer Arm No No 12 NA Pradera, Plaque Thorax No No 12 Destructive lesion Septum NA NA NA 5 D Ulcer Leg No No 4 L. panamensis Trujillo, D1015 D1016 D1017 D1018 Ulcer Leg No No 4 Ulcer Leg No No Plaque Head No No 1.5 L. panamensis Vijes, 25 6 Ulcer Thorax 8 7 No No 1 L. panamensis Cali, Ulcer Thorax 7 9 No No 1 Ulcer Thorax 5 11 No No 1 Ulcer Thorax 8 6 No No 1 Ulcer Thorax 7 6 No No 1 Ulcer Arm 14 8 No No Ulcer Head L. braziliensis Timba, Cauca 20 2 Ulcer Arm 14 7 No No 2 L. panamensis Nubita, Choco 74 1 Filtrum and Right nostril lost D1020 D1021 Ulcer Arm 5 5 No No 1 Head NA NA NA 96 NA Caicedonia, 59 1 Ulcer Thorax No No 2 L. braziliensis Cali, 24 1 Ulcer Arm L. panamensis Santander de Quilichao, Cauca No 641
5 D1022 D1023 D1024 D1025 D1026 D1027 D1028 D1029 D Ulcer Head 6 10 No 0.6 L. panamensis Cali, 21 1 Plaque Head No No 3 NA Buenaventura, 34 1 Granulomatous lesion Arm NA Cali, 57 2 Ulcer Arm NA Buenaventura, Nodule Arm Ulcer Neck 8 5 No No 2 L. panamensis Cali, NA 23 5 Ulcer Leg L. panamensis El Charco, Nariño Ulcer Leg Nodule Leg Nodule Leg Other Leg Ulcer Arm No No 1.5 L. panamensis Chinchina, Caldas Ulcer Thorax 6 9 No No Ulcer Head No 1.5 NA Buenaventura, 19 1 Ulcer Head No No 1.5 L. panamensis Buenaventura, NOTE. LAD, lymphadenopathy; NA, not available; ND, not determined. a Patient with mucocutaneous leishmaniasis.
6 healthy donors who had not been exposed to Leishmania transmission. PCR PCR were performed using the cloned 700-bp sequence of kdna in a PCR 2.1 TOPO vector (Invitrogen) from L. panamensis strain MHOM/CO/86/1166; promastigotes of this strain were used as positive controls. Each PCR run included negative controls for PCR reagents and sample extraction. Primer pair LV-B1 were used to amplify Leishmania kdna using methods described elsewhere ( [17] and Ramirez et al, unpublished data) with the following modifications: the annealing temperature was increased to 66 C for 40 s, and a final extension at 72 C for 1 min was added. The final PCR volume was 25 ml, containing 28 ng total DNA from each sample, as determined by use of an ND-1000 spectrophotometer (Thermo Scientific NanoDrop). Electrophoresis and Hybridization The Leishmania (Viannia) specific amplification product was 700 bp. Southern blot analysis was performed with 10 ml of each PCR product separated in 1% agarose gels at 90 volts for 45 minutes; bands were visualized and recorded in a GelDoc 2000 (BioRad). The transfer was carried out by capillary action overnight onto a nylon membrane (Amersham Hybond-N+) using 10 sodium chloride sodium citrate (1.5 mol/l NaCl and 0.15 mol/l sodium citrate). DNA was fixed to the membrane with ultraviolet light in a Crosslinker (Spectronics) for 30 s in automatic mode. For hybridization and detection, the AlkPhos Direct Labeling and Detection System kit (Amersham Biosciences) was used in accordance with to the manufacturer s instructions. Hybridization was conducted at 60 C with a 700- bp kdna minicircle probe that had been purified and cloned into PCR 2.1 TOPO vector (Invitrogen). Radiographic films were processed automatically using a Computer Classic EOS developer (Agfa). Patient characteristics. Twenty-eight patients between 19 and 74 years of age were included in the study. Twenty-six presented with cutaneous lesions, and 2 presented with mucocutaneous disease. There were 25 men (89%) and 3 women (11%). The duration of lesions at the time of diagnosis ranged from!1 month to 8 years, and the majority of lesions were ulcerated. There were 14 patients (50%) with 11 active lesion (table 1). Leishmania species. Leishmania were isolated from 22 (79%) of the 28 patients at diagnosis. Sixteen isolates (73%) were identified as L. panamensis, 4 (18%) as L. braziliensis, and 2 (9%) as L. guyanensis. Leishmania kdna was detected in the apparently unaffected mucosal tissues of patients with cutaneous disease caused by L. panamensis, L. braziliensis, and L. guyanensis. PCR and Southern blot analysis. Overall, the mucosal tissues of 23 (82%) of 28 patients yielded Leishmania kdna (figure 1); only 2 of these patients had mucosal lesions. Nasal mucosa samples were the samples most frequently positive for Leishmania kdna (14 [58%] of 24), followed by tonsilar mucosa samples (13 [46%] of 28), and conjunctiva samples (6 [25%] of 24) (table 2). The location of cutaneous lesions was unrelated to the detection of Leishmania kdna in mucosal tissues; 11 of 14 patients with lesions on the face and/or head or neck and 12 of 14 patients with lesions only on their arms or legs had mucosal swab samples that were PCR positive. Of 24 cutaneous and mucocutaneous lesion swab samples analyzed, all but 2 (92%) were positive for Leishmania. Eighteen (63%) of 28 patients had samples that were positive by PCR alone; Southern blot hybridization revealed 6 additional patients with mucosal tissue samples that were positive for Leishmania and confirmed the specificity of PCR. DISCUSSION The availability of highly sensitive and specific molecular genetic technology and the development of less invasive, technically simple sampling methods have opened the way for early and efficient diagnosis and a greater understanding of the natural history of Leishmania infection in the human host. Indeed, RESULTS Figure 1. Amplified Leishmania (Viannia) kinetoplast minicircle DNA (kdna) product from swab samples of different sites using LV-B1 primers. A, Detection in 1% agarose gel. Lane 1, molecular ladder; lane 2, conjunctiva sample from a healthy donor; lane 3, tonsil sample from a healthy donor; lane 4, nasal mucosa sample from a healthy donor; lane 5, negative extraction control; lane 6, negative polymerase chain reaction (PCR) control; lane 7, positive PCR control; lane 8, conjunctiva sample from patient D1009; lane 9, tonsil sample from patient D1014; lane 10, tonsil sample from patient D1019; lane 11, nasal mucosa sample from patient D1009; lane 12, nasal mucosa sample from patient D1014; lane 13, mucosal lesion sample from patient D1019; lane 14, cutaneous lesion sample from patient D1020. B, Specificity confirmation and enhancement of detection by use of Southern blot analysis with a cloned 700-bp sequence of L. panamensis kdna. Leishmania in Unaffected Mucosal Tissues JID 2009:200 (15 August) 643
7 Table 2. Molecular analysis of swab samples from lesions and unaffected tissues of 28 patients with leishmaniasis. Patient code Swab sample result, by source and test type Tonsil Conjunctiva Nasal Lesion PCR SB PCR SB PCR SB PCR SB D NA NA NA NA NA NA D NA NA NA NA NA NA D1005 NA NA NA NA NA NA D1006 NA NA NA NA NA NA D D D D D D D1013 a D D D D D D1019 a D D D D D D D D D D D Total, proportion (%) 9/28 (32) 13/28 (46) 2/24 (8) 6/24 (25) 10/24 (42) 14/24 (58) 22/24 (92) 22/24 (92) NOTE. +, positive for Leishmania;, negative for Leishmania; NA, not available (used in the optimization process only and unavailable for analysis); PCR, polymerase chain reaction; SB, Southern blot. a Patient with mucocutaneous leishmaniasis. molecular diagnosis provides a new gold standard for the diagnosis of dermal leishmaniasis [18], especially for disease presentations that involve a low parasite burden, such as mucosal leishmaniasis [19]. The findings of this study show that the efficiency of recovery and detection of parasite kdna from swab samples of mucosal tissues analyzed with a combination of PCR using the LV-B1 primer pair and Southern blot hybridization provides noninvasive access to mucosal tissues and a promising diagnostic alternative to biopsy and histopathological evaluation. The presence of Leishmania in mucosal tissues in the apparent absence of pathology may be a common feature of the natural history of infection due to Leishmania species of the Viannia subgenus. The asymptomatic presence of Leishmania in mucosal tissues can now be readily assessed in infections due to different species by using the approach described in this study. Remarkably, in this patient series, the asymptomatic presence of Leishmania in mucosal tissue was the rule rather than the exception, being demonstrated in 21 (81%) of 26 patients who had cutaneous disease only. This finding suggests that metastasis to and presence of parasites in mucosal tissues per se does not explain the pathogenesis of mucosal leishmaniasis and supports the idea that the host response plays a role in the pathogenesis of mucosal disease [20, 21]. Case reports and series have demonstrated that a wide range of species of Leishmania from both the Old and New Worlds can invade and cause disease in mucosal tissues of the nasopharynx [22]. L. donovani and L. infantum have been identified in gastrointestinal mucosa [23], the genitourinary tract [24], and the eye and lacrimal excretory system [25, 26]. Although 644 JID 2009:200 (15 August) Figueroa et al
8 these clinical manifestations of infection affecting the gamut of mucosal surfaces involved viscerotropic species of Leishmania, they portray a pattern of dissemination to mucosal tissues that in the light of the findings of this study may be more frequent and common than previously suspected for other species of Leishmania. To our knowledge, this is the first demonstration of Leishmania in the apparently normal mucosal tissues of patients with cutaneous leishmaniasis. The high frequency of kdna in the nasal mucosa accords with the nasal septum being the most frequent location of mucosal lesions [6, 7]. Interestingly, cytologic evaluation of nasal samples from cutaneous and mucocutaneous patients revealed a correlation between the presence of inflammatory cells and mucosal pathology in L. braziliensis infection [27]. Leishmania have been cultured from the tonsils, nasal secretions, and urine of patients with visceral leishmaniasis [28, 29]. Nasal secretions in particular yielded propagable Leishmania in a high proportion of patients. The finding that nasal swab samples were the most common source of kdna in this study suggests that dissemination to nasal mucosa may also be a common feature in cutaneous leishmaniasis caused by Leishmania (Viannia) species. The presence of parasites in tonsilar tissue is consistent with lymphatic dissemination [30] to mucosal sites. Nevertheless hematologic dissemination also occurs in mucosal leishmaniasis, as shown by hemoculture [10, 31]; PCR and Southern blot analysis have provided evidence of parasitemia in at least 30% of blood samples from patients with cutaneous disease [6] and in asymptomatically infected individuals [26]. In a separate study, Leishmania (Viannia) kdna was amplified from blood monocytes from 19 (68%) of the 28 patients included in this study (I.C.R. et al, unpublished data). kdna was amplified from both mucosal tissues and blood for 16 (58%) of the 28 patients. Under the conditions of this study, the LV-B1 primer pair had a sensitivity of 0.2 parasites per reaction, and the 700-bp size of the amplification product distinguished Leishmania species of the Viannia subgenus from other trypanosomatids. Cross-hybridization with the amplification products of other trypanosomatids did not occur, and human DNA was not amplified (Vergel et al [11] and Ramirez et al, unpublished data). The validity of these findings is substantiated by the specificity of the amplification and hybridization, the use of negative extraction and PCR mix controls, and the absence of kdna amplification for the mucosal swab samples from 2 healthy donors. The asymptomatic presence of kdna in tonsilar and mucosal tissues, unaffected skin [17], and blood before and after successful treatment [11, 30] substantiates that Leishmania (Viannia) species commonly disseminate from the inoculation site, even in localized, cutaneous disease. Noninvasive swab sampling, PCR, and molecular hybridization allowed us to examine apparently unaffected tissue as well as diseased mucosal tissue and to demonstrate that Leishmania (Viannia) species are present in apparently unaffected mucosa. The results of this exploratory study provide proof-of-principle for this approach to the diagnosis of mucosal leishmaniasis. Acknowledgments We gratefully acknowledge the assistance of Maria Consuelo Miranda, MD, MSc, in the clinical assessment and management of patients; Mauricio Perez and James Becerra in the design of the data base and statistical analyses; Rafael Gongora for the typing of Leishmania isolates; and Cesar Ramirez in the standardization of molecular methods. References 1. Saravia NG, Holguin AF, McMahon-Pratt D, D Alessandro A. Mucocutaneous leishmaniasis in Colombia: Leishmania braziliensis subspecies diversity. Am J Trop Med Hyg 1985; 34: Abdalla RE, El Hadi A, Ahmed MA, El Hassan AM. Sudan mucosal leishmaniasis. Trans R Soc Trop Med Hyg 1975; 69: Barnetson RS, Ridley RS, Wheate HW. A form of muco-cutaneous leishmaniasis in the Old World. Trans R Soc Trop Med Hyg 1978;72: el-hassan AM, Meredith SE, Yagi HI, et al. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment. Trans R Soc Trop Med Hyg 1995; 89: Barral A, Pedral-Sampaio D, Grimaldi Junior G, et al. Leishmaniasis in Bahia, Brazil: Evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 1991; 44: Marsden P L-CE, Lago E, Cuba C, Barreto A, Costa JML, Jones TC. Human mucocutaneous leishmaniasis in Tres Braços, Bahia-Brazil, an area of Leishmania braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 1984; 17: Osorio LE, Castillo CM, Ochoa MT. Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics. Am J Trop Med Hyg 1998; 59: al-gindan Y, Kubba R, el-hassan AM, Omer AH, Kutty MK, Saeed MB. Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement. Int J Dermatol 1989; 28: Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am J Trop Med Hyg 1995; 53: Martinez JE A, Arias L, Escobar MA, Saravia NG. Haemoculture of Leishmania (Viannia) braziliensis from two cases of mucosal leishmaniasis: re-examination of haematogenous dissemination. Trans R Soc Trop Med Hyg 1992; 86: Vergel C, Palacios R, Cadena H, et al. Evidence for Leishmania (Viannia) parasites in the skin and blood of patients before and after treatment. J Infect Dis 2006; 194: Marsden PD. Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Tres Braços, Bahia-Brazil. Rev Soc Bras Med Trop 1994; 27: Boaventura VS, Cafe V, Costa J, et al. Concomitant early mucosal and cutaneous leishmaniasis in Brazil. Am J Trop Med Hyg 2006; 75: Weigle KA, de Davalos M, Heredia P, Molineros R, Saravia NG, D Alessandro A. Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods. Am J Trop Med Hyg 1987; 36: Saravia NG, Weigle K, Navas C, et al. Heterogeneity, geographic distribution, and pathogenicity of serodemes of Leishmania Viannia in Colombia. Am J Trop Med Hyg 2002; 66: Saravia NG, Segura I, Holguin AF, Santrich C, Valderrama L, Ocampo Leishmania in Unaffected Mucosal Tissues JID 2009:200 (15 August) 645
9 C. Epidemiologic, genetic, and clinical associations among phenotypically distinct populations of Leishmania (Viannia) in Colombia. Am J Trop Med Hyg 1998; 59: Vergel C, Walker J, Saravia NG. Amplification of human DNA by primers targeted to Leishmania kinetoplast DNA and post-genome considerations in the detection of parasites by a polymerase chain reaction. Am J Trop Med Hyg 2005; 72: Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 2002; 40: Ovalle Bracho C, Porras de Quintana L, Muvdi Arenas S, Rios Parra M. Polymerase chain reaction with two molecular targets in mucosal leishmaniasis diagnosis: a validation study. Mem Inst Oswaldo Cruz 2007; 102: Blackwell JM. Tumour necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today 1999; 15: Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002;70: Naik SR, Vinayak VK, Talwar P, et al. Visceral leishmaniasis masquerading as a nasopharyngeal tumour. Report of a case. Trans R Soc Trop Med Hyg 1978; 72: Balkhair A, Ben Abid F. Gastric and cutaneous dissemination of visceral leishmaniasis in a patient with advanced HIV. Int J Infect Dis 2008; 12: Mebrahtu YB, Hendricks LD, Oster CN, et al. Leishmania donovani parasites in the nasal secretions, tonsillopharyngeal mucosa, and urine centrifugates of visceral leishmaniasis patients in Kenya. Am J Trop Med Hyg 1993; 48: Dechant W, Rees PH, Kager PA, Klauss V, Adala H. Post kala-azar uveitis. Br J Ophthalmol 1980; 64: Hoyama E, Schellini SA, Stolf HO, Nakajima V. Lacrimal excretory system sequelae in patients treated for leishmaniasis. Arq Bras Oftalmol 2006; 69: Guerreiro JB, Cruz AA, Barral A, Lessa HA, Rocha H, Carvalho EM. Mucosal leishmaniasis: quantitative nasal cytology as a marker of disease activity and indicator of healing. Ann Otol Rhinol Laryngol 2000; 109: Forkner CE, Zia LS. Viable Leishmania donovani in nasal and oral secretions of patients with kala-azar and the bearing of this finding on the transmission of the disease. J Exp Med 1934; 59: Available at: Accessed 17 June Kouyialis S, Archontakis S, Bilinis C, et al. Report of an atypical case of leishmaniasis presented as acute tonsillitis in an immunocompetent patient. Scand J Infect Dis 2005; 37: Schubach A, Haddad F, Oliveira-Neto MP, et al. Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis 1998; 178: Bowdre JH, Campbell JL, Walker DH, Tart DE. American mucocutaneous leishmaniasis. Culture of a Leishmania species from peripheral blood leukocytes. Am J Clin Pathol 1981; 75: JID 2009:200 (15 August) Figueroa et al
NIH Public Access Author Manuscript Trans R Soc Trop Med Hyg. Author manuscript; available in PMC 2013 June 01.
NIH Public Access Author Manuscript Published in final edited form as: Trans R Soc Trop Med Hyg. 2012 June ; 106(6): 376 381. doi:10.1016/j.trstmh.2012.03.007. A proposed new clinical staging system for
More informationCase Report Development of Cutaneous Leishmaniasis after Leishmania Skin Test
Case Reports in Medicine Volume 2011, Article ID 631079, 4 pages doi:10.1155/2011/631079 Case Report Development of Cutaneous Leishmaniasis after Leishmania Skin Test Paulo R. Machado, 1, 2 Augusto M.
More informationEvidence for Leishmania (Viannia) Parasites in the Skin and Blood of Patients Before and After Treatment
MAJOR ARTICLE Evidence for Leishmania (Viannia) Parasites in the Skin and Blood of Patients Before and After Treatment Carolina Vergel, Ricardo Palacios, a Horacio Cadena, Claudia Jimena Posso, Liliana
More informationdata indicating a 31% efficacy in northwest Colombia. 6
Am. J. Trop. Med. Hyg., 64(3, 4), 2001, pp. 187 193 Copyright 2001 by The American Society of Tropical Medicine and Hygiene TREATMENT FAILURE IN CHILDREN IN A RANDOMIZED CLINICAL TRIAL WITH 10 AND 20 DAYS
More informationLeishmaniasis has been documented in several countries,
Rev Bras Otorrinolaringol 2007;73(6):843-7. REVIEW ARTICLE Mucosal leishmaniasis: epidemiological and clinical aspects. Marcus Miranda Lessa 1, Hélio Andrade Lessa 2, Thomas W. N. Castro 3, Adja Oliveira
More informationTreatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
MAJOR ARTICLE Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B Paulo R. L. Machado, 1,2 Maria Elisa A. Rosa, 1 Luís H. Guimarães, 1,2 Fernanda V. O. Prates, 1 Adriano Queiroz, 1,2
More informationLesion aspirate culture for the diagnosis and isolation of Leishmania spp. from patients with cutaneous leishmaniasis
62 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 104(1): 62-66, February 2009 Lesion aspirate culture for the diagnosis and isolation of Leishmania spp. from patients with cutaneous leishmaniasis Zélia Maria
More informationTreatment of Cutaneous Leishmaniasis with Allopurinol and Stibogluconate
165 Treatment of Cutaneous Leishmaniasis with Allopurinol and S. Martinez, M. Gonzalez, and M. E. Vernaza From the Department of Internal Medicine, University of Cauca, Popayan, and the University Hospital
More informationLaboratory diagnosis of Blood and tissue flagellates
Laboratory diagnosis of Blood and tissue flagellates (Leishmania and trypanosma) Sarah Alharbi Clinical Laboratory department Collage of Applied Medical Sciences King Saud University Leishmania and trypanosma:
More informationNew Insights into Diagnosing Leishmaniasis
New Insights into Diagnosing Leishmaniasis Eric Zini Snow meeting, 13 March 2009 Climate Variability and Visceral Leishmaniasis in Europe WHO/TDR, Jan. 2008 Late Eighties Maroli et al., Trop Med Int Health
More informationWelcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar
Welcome to the Jungle! Dr Aileen Oon, 2017 Microbiology Registrar AA 55M presented with sores on left olecranon and umbilical area Umbilical sores present for 3 weeks Left olecranon lesions for 1 week
More informationCutaneous Leishmaniasis : Global overview
Cutaneous Leishmaniasis : Global overview Meeting of stakeholders for selected Health R&D Demostration Projects, 7-10 May 2014, WHO, Geneva Dr. Daniel Argaw Dagne, NTD/WHO CSR - DDC AFRO Leishmaniasis
More informationFAMILIAL AGGREGATION OF MUCOSAL LEISHMANIASIS IN NORTHEAST BRAZIL
Am. J. Trop. Med. Hyg., 73(1), 2005, pp. 69 73 Copyright 2005 by The American Society of Tropical Medicine and Hygiene FAMILIAL AGGREGATION OF MUCOSAL LEISHMANIASIS IN NORTHEAST BRAZIL LÉA CASTELLUCCI,*
More informationOriginal Article Comparison of fine needle aspiration with biopsy in the diagnosis of cutaneous leishmaniasis Ikramullah Khan, Rifat Yasmin
Original Article Comparison of fine needle aspiration with biopsy in the diagnosis of cutaneous leishmaniasis Ikramullah Khan, Rifat Yasmin Department of Dermatology, Pakistan Institute of Medical Sciences,
More informationNew insights on leishmaniasis in immunosuppressive conditions
New insights on leishmaniasis in immunosuppressive conditions Javier Moreno Immunoparasitology Unit WHO Collaborative Center for Leishmaniasis Centro Nacional de Microbiología INSTITUTO DE SALUD CARLOS
More informationCHAPTER 4 RESULTS. showed that all three replicates had similar growth trends (Figure 4.1) (p<0.05; p=0.0000)
CHAPTER 4 RESULTS 4.1 Growth Characterization of C. vulgaris 4.1.1 Optical Density Growth study of Chlorella vulgaris based on optical density at 620 nm (OD 620 ) showed that all three replicates had similar
More informationTropical medicine rounds
Oxford, IJD International 0011-9059 Blackwell 41 UK Science, Journal Ltd 2002 of Dermatology Tropical medicine rounds Cutaneous André Báfica, Leishmaniasis Fabiano Oliveira, Luiz A. R. Freitas, Eliane
More informationThe Most Common Parasitic Infections In Yemen. Medical Parasitology
The Most Common Parasitic Infections In Yemen Medical Parasitology ﻓﺎﯾز اﻟﺧوﻻﻧﻲ / د 2 : is a vector-borne disease that transmitted by sandflies and caused by obligate intracellular protozoa of the genus
More informationGastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR
Gastric Carcinoma with Lymphoid Stroma: Association with Epstein Virus Genome demonstrated by PCR Pages with reference to book, From 305 To 307 Irshad N. Soomro,Samina Noorali,Syed Abdul Aziz,Suhail Muzaffar,Shahid
More informationSUMMARY. Cutaneous leishmaniasis with only skin involvement: single to multiple skin ulcers, satellite lesions and nodular lymphangitis.
SUMMARY Leishmaniasis is a disease affecting predominantly people in the developing countries; 350 million people worldwide are at risk and yearly more than 2 million new cases occur. Leishmaniasis is
More informationClinical and immunopathological aspects of disseminated cutaneous leishmaniasis
Acta Tropica, 56( 1994)315-325 0 1994 Elsevier Science B.V. All rights reserved 0001-706X/94/$07.00 315 ACTROP 00364 Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis E.M.
More informationMore than 98 countries affected by Leishmaniasis
More than 98 countries affected by Leishmaniasis ACL In many urban & sub urban areas (8 provinces) Tehran, Mashhad, Neishabur, Shiraz, Kerman, Bam (Sharifi et al. 2011) ZCL In 2012, totally ( ZCL & ACL)
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationCutaneous Leishmaniasis in a Chinese man returning from the Amazon forest in Brazil
Hong Kong J. Dermatol. Venereol. (2013) 21, 79-83 Case Report Cutaneous Leishmaniasis in a Chinese man returning from the Amazon forest in Brazil JTHT Yu and SY Wong A 60-year-old man presented with ulcerated
More informationHuman Influenza A (Swine Flu) Rapid test
Human Influenza A (Swine Flu) Rapid test Cat.No: DTSXY-Z9 Lot. No. (See product label) Size 20T Intended use The Influenza A (Swine Flu) test is a rapid chromatographic immunoassay for the qualitative
More informationProduct Manual. Omni-Array Sense Strand mrna Amplification Kit, 2 ng to 100 ng Version Catalog No.: Reactions
Genetic Tools and Reagents Universal mrna amplification, sense strand amplification, antisense amplification, cdna synthesis, micro arrays, gene expression, human, mouse, rat, guinea pig, cloning Omni-Array
More informationImpavido. (miltefosine) New Product Slideshow
Impavido (miltefosine) New Product Slideshow Introduction Brand name: Impavido Generic name: Miltefosine Pharmacological class: Antileishmanial agent Strength and Formulation: 50mg; hard gel capsules Manufacturer:
More informationBlood Smears Only 6 October Sample Preparation and Quality Control 15B-K
NEW YORK STATE Parasitology Proficiency Testing Program Blood Smears Only 6 October 5 The purpose of the New York State Proficiency Testing Program in the category of Parasitology - Blood Smears Only is
More informationLeishmanial Antigens in the Diagnosis of Active Lesions and Ancient Scars of American Tegumentary Leishmaniasis Patients
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 96(7): 987-996, October 2001 Leishmanial Antigens in the Diagnosis of Active Lesions and Ancient Scars of American Tegumentary Leishmaniasis Patients Armando
More informationEar, nose and throat manifestations of mucocutaneous Leishmaniasis: a literature review
Acta Biomed 2014; Vol. 85, N. 1: 3-7 Mattioli 1885 Review Ear, nose and throat manifestations of mucocutaneous Leishmaniasis: a literature review Francesca Marra, Maria Celeste Chiappetta, Vincenzo Vincenti
More informationLeishmaniasis. CDR R.L. Gutierrez Oct 2014
Leishmaniasis CDR R.L. Gutierrez Oct 2014 Overview Protozoan parasite(s) of tissue and WBCs Many species / Many Syndromes (Cutaneous / Visceral) Pathogen: Location - Old World vs. New World Host: Immune
More informationAtypical cutaneous leishmaniasis cases display elevated antigen-induced interleukin-10
Parasite Immunology, 2007, 29, 277 282 DOI: 10.1111/j.1365-3024.2007.00944.x Blackwell ORIGINAL Immune response Publishing ARTICLE in atypical Ltd cutaneous leishmaniasis Atypical cutaneous leishmaniasis
More informationSummary of Cases & Epidemiology Aspects of Leishmaniasis in Thailand
Summary of Cases & Epidemiology Aspects of Leishmaniasis in Thailand Sukmee T. 1, Mungthin M. 2, Apiwathanasorn C. 3, Leelayoova S. 2 1 Department of Microbiology, Phramongkutklao College of Medicine 2
More informationComparison of light microscopy and nested PCR assay in detecting of malaria mixed species infections in an endemic area of Iran
Comparison of light microscopy and nested PCR assay in detecting of malaria mixed species infections in an endemic area of Iran Aliehsan Heidari, Manizheh Nourian, Hossein Keshavarz Associate Prof. Dept.
More informationHAEMOFLAGELLATES. Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine
HAEMOFLAGELLATES Dr. Anuluck Junkum Department of Parasitology Faculty of Medicine Objective Can describe the morphology, life cycle, pathology, diagnosis and prevention of Leishmania spp. and Trypanosoma
More informationMajor Article. CD8+ T cells in situ in different clinical forms of human cutaneous leishmaniasis
Major Article Revista da Sociedade Brasileira de Medicina Tropical 46(6):728-734, Nov-Dec, 213 http://dx.doi.org/1.159/37-8682-174-213 CD8+ T cells in situ in different clinical forms of human cutaneous
More informationAnimal models for infectious diseases caused by parasites: Leishmaniasis
Drug Discovery Today: Disease Models Vol. 1, No. 1 2004 DRUG DISCOVERY TODAY DISEASE MODELS Editors-in-Chief Jan Tornell AstraZeneca, Sweden Denis Noble University of Oxford, UK Infectious diseases Animal
More informationMolecular diagnosis of. leishmaniasis. Carlos Alberto P Tavares, Ana Paula Fernandes and Maria Norma Melo. Author Proof
Review Molecular diagnosis of leishmaniasis Carlos Alberto P Tavares, Ana Paula Fernandes and Maria Norma Melo CONTENTS Traditional leishmaniasis diagnostic approaches Diagnosis of visceral leishmaniasis
More informationMitochondrial DNA Isolation Kit
Mitochondrial DNA Isolation Kit Catalog Number KA0895 50 assays Version: 01 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 General Information... 4 Materials
More informationVisceral leishmaniasis: an endemic disease with global impact
Visceral leishmaniasis: an endemic disease with global impact Professor Olivier Lortholary, MD, PhD Department of Infectious and Tropical diseases Hôpital Necker-Enfants Malades Université Paris Descartes
More informationTITLE: Association Between an Emerging Disseminated form of Leishmaniasis
JCM Accepts, published online ahead of print on 3 October 2012 J. Clin. Microbiol. doi:10.1128/jcm.02064-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 TITLE: Association
More informationActa Dermatovenerol Croat 2008;16(2):60-64 CLINICAL ARTICLE
2008;16(2):60-64 CLINICAL ARTICLE Clinical Efficacy of Intramuscular Meglumine Antimoniate Alone and in Combination with Intralesional Meglumine Antimoniate in the Treatment of Old World Cutaneous Leishmaniasis
More information2.Trichomonas vaginalis
2.Trichomonas vaginalis 1. Pathogenic to human &causes vaginitis (trichomoniasis). 2. troph. Is round or pear like in shape, contains 4-6 flagella, all originating from anterior end & only one extend posteriorly.
More informationA Novel Noninvasive Method for Diagnosis of Visceral Leishmaniasis by. rk39 Test in Sputum Samples
JCM Accepts, published online ahead of print on 0 June 00 J. Clin. Microbiol. doi:0./jcm.00-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationTISSUE COLLECTION. SCPA 603- Histopathological Techniques for Routine and Research
TISSUE COLLECTION SCPA 603- Histopathological Techniques for Routine and Research Somphong Narkpinit, MD. Department of Pathobiology Faculty of Science, Mahidol University somphong.nar@mahidol.ac.th Learning
More informationPost-kala-azar Dermal Leishmaniasis Associated With AIDS*
BJID 2003; 7 (June) 229 Post-kala-azar Dermal Leishmaniasis Associated With AIDS* Achiléa Bittencourt, Nancy Silva, Andréa Straatmann, Victor Luiz Correia Nunes, Ivonise Follador and Roberto Badaró Universitary
More information(From the Department of Medicine, the Peiping Union Medical College, Peiping, China)
Published Online: 1 April, 1934 Supp Info: http://doi.org/10.1084/jem.59.4.491 Downloaded from jem.rupress.org on October 9, 2018 VIABLE LEISHMANIA DONOVANI IN NASAL AND ORAL SECRETIONS OF PATIENTS WITH
More informationPersistence of Leishmania Parasites in Scars after Clinical Cure of American Cutaneous Leishmaniasis: Is There a Sterile Cure?
MAJOR ARTICLE Persistence of Leishmania Parasites in Scars after Clinical Cure of American Cutaneous Leishmaniasis: Is There a Sterile Cure? Mitzi G. Mendonça, 1,a Maria E. F de Brito, 2 Eduardo H. G.
More informationWMLN Case Study. Necrotizing Palate Biopsy Specimen. Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP)
WMLN Case Study Necrotizing Palate Biopsy Specimen Youngmi Kim Sr. Microbiologist TB Lab & Parasitology Lab MS, M(ASCP) 44 year old male from Honduras Immigrated to US 12 years ago to WI 4 years ago Seen
More informationNeglected Diseases (NDs) Landscape in Brazil and South America
Frontiers in Science on Neglected Diseases 13 th November 2014 Neglected Diseases (NDs) Landscape in Brazil and South America Jeffrey Shaw São Paulo University Biomedical Sciences Institute jeffreyj@usp.br
More informationKit Components Product # EP42720 (24 preps) MDx 2X PCR Master Mix 350 µl Cryptococcus neoformans Primer Mix 70 µl Cryptococcus neoformans Positive
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: 866-667-4362 (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Cryptococcus neoformans End-Point PCR Kit Product# EP42720 Product
More informationTuberculosis - clinical forms. Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases
Tuberculosis - clinical forms Dr. A.Torossian,, M.D., Ph. D. Department of Respiratory Diseases 1 TB DISEASE Primary Post-primary (Secondary) Common primary forms Primary complex Tuberculosis of the intrathoracic
More informationprepared from Leishmania panamensis Citation 日本熱帯医学会雑誌, vol.19(2), pp ; 1
NAOSITE: Nagasaki University's Ac Title Author(s) Evaluation and characterization of prepared from Leishmania panamensis Furuya, Masato; Nonaka, Shigeo; Gom Yoshihisa Citation 日本熱帯医学会雑誌, vol.19(2), pp.209-217;
More informationRapid-VIDITEST Swine Flu
Rapid-VIDITEST Swine Flu One Step Influenza type A Antigen Card test. Instruction manual Producer: VIDIA spol. s r.o., Nad Safinou II 365, 252 50 Vestec, Czech Republic, Tel.: +420 261 090 565, www.vidia.cz
More informationLeishmaniasis. MAJ Kris Paolino September 2014
Leishmaniasis MAJ Kris Paolino September 2014 Thanks to COL (Ret) Kent Kester MAJ Leyi Lin http://www.niaid.nih.gov/topics/leishmaniasis History Sir William Boog Leishman (1865-1926) Matriculated at the
More informationPost Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels
Post Kala-azar Dermal Leishmaniasis (PKDL) from the field to the cellular and the subcellular levels A M EL Hassan Institute of Endemic Diseases University of Khartoum Introduction PKDL is a VL related
More informationSingle-Step Multiplex PCR Assay for Characterization of New World Leishmania Complexes
JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 1989 1995 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Single-Step Multiplex PCR Assay for
More informationProduct # Kit Components
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Pneumocystis jirovecii PCR Kit Product # 42820 Product Insert Background Information
More informationLaboratory diagnosis of congenital infections
Laboratory diagnosis of congenital infections Laboratory diagnosis of HSV Direct staining Tzanck test Immunostaining HSV isolation Serology PCR Tzanck test Cell scrape from base of the lesion smear on
More information~Trichinella Spiralis:
Musculoskeletal System **Today we are going to talk about the parasites that affect the musculoskeletal system ~Trichinella Spiralis: It s a small nematode that measures to about 2-3mm in length. In general
More informationChildren with Visceral Leishmaniasis Presented to Omdurman Emergency Hospital for Children
Original Article Children with Visceral Leishmaniasis Presented to Omdurman Emergency Hospital for Children Elfakey Walyeldinl, Ahmed Muawial, Mohamed Abdurrahman2 and Suwar M 03 Department of Paediatrics
More informationHepatitis B Virus Genemer
Product Manual Hepatitis B Virus Genemer Primer Pair for amplification of HBV Viral Specific Fragment Catalog No.: 60-2007-10 Store at 20 o C For research use only. Not for use in diagnostic procedures
More informationSusceptibility of Spiny Rats (Proechimys semispinosus) to Leishmania (Viannia) panamensis and Leishmania (Leishmania) chagasi
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 97(6): 887-892, September 2002 887 Susceptibility of Spiny Rats (Proechimys semispinosus) to Leishmania (Viannia) panamensis and Leishmania (Leishmania) chagasi
More informationCase Report Occupationally Acquired American Cutaneous Leishmaniasis
Case Reports in Dermatological Medicine Volume 2012, Article ID 279517, 4 pages doi:10.1155/2012/279517 Case Report Occupationally Acquired American Cutaneous Leishmaniasis Maria Edileuza Felinto de Brito,
More informationAngélica Mera-Ramírez 1, Andrés Castillo 2, Yenifer Orobio 1, María Adelaida Gómez 1 and Carolina Gallego-Marin 1,3*
Mera-Ramírez et al. BMC Infectious Diseases (2017) 17:177 DOI 10.1186/s12879-017-2281-4 RESEARCH ARTICLE Open Access Screening of TNFα, IL-10 and TLR4 single nucleotide polymorphisms in individuals with
More informationExtensive Kaposi's sarcoma in a HIV positive patient: A case report
ISPUB.COM The Internet Journal of Infectious Diseases Volume 7 Number 1 Extensive Kaposi's sarcoma in a HIV positive patient: A case report G Lopez, Y Graza Citation G Lopez, Y Graza.. The Internet Journal
More informationFor in vitro Veterinary Diagnostics only. Kylt Rotavirus A. Real-Time RT-PCR Detection.
For in vitro Veterinary Diagnostics only. Kylt Rotavirus A Real-Time RT-PCR Detection www.kylt.eu DIRECTION FOR USE Kylt Rotavirus A Real-Time RT-PCR Detection A. General Kylt Rotavirus A products are
More informationDifferential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis
The Journal of Infectious Diseases BRIEF REPORT Differential Expression of the Eicosanoid Pathway in Patients With Localized or Mucosal Cutaneous Leishmaniasis Jaqueline França-Costa, 1 Bruno B. Andrade,
More informationEastern Mediterranean Health Journal, Vol. 9, No. 4,
Eastern Mediterranean Health Journal, Vol. 9, No. 4, 2003 837 Antimony-resistant Leishmania donovani in eastern Sudan: incidence and in vitro correlation M.G. Abdo, 1 W.M. Elamin, 1 E.A.G. Khalil 1 and
More informationAnalysis of small RNAs from Drosophila Schneider cells using the Small RNA assay on the Agilent 2100 bioanalyzer. Application Note
Analysis of small RNAs from Drosophila Schneider cells using the Small RNA assay on the Agilent 2100 bioanalyzer Application Note Odile Sismeiro, Jean-Yves Coppée, Christophe Antoniewski, and Hélène Thomassin
More informationIntralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
512 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 111(8): 512-516, August 2016 Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian
More informationCutaneous Leishmania
DISCLOSURE OF RELEVANT RELATIONSHIPS WITH INDUSTRY Cutaneous Leishmania Ibrahim Khalifeh, MD I do not have any relevant relationships with industry. Cutaneous Leishmania: Is it a Legend? Ibrahim Khalifeh,
More information1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir
New Influenza A Virus Real Time RT-PCR Kit User Manual LT028310RRFY - 1 - 1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal
More informationTrypanosomiasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course
Trypanosomiasis WRAIR- GEIS 'Operational Clinical Infectious Disease' Course UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy
More informationRegulatory T Cells in the Pathogenesis and Healing of Chronic Human Dermal Leishmaniasis Caused by Leishmania (Viannia) Species
Regulatory T Cells in the Pathogenesis and Healing of Chronic Human Dermal Leishmaniasis Caused by Leishmania (Viannia) Species Daniel Rodriguez-Pinto 1 *, Adriana Navas 1,Víctor Manuel Blanco 1, Lady
More informationStandardization of a molecular method for epidemiologic identification of Leishmania strains
Standardization of a molecular method for epidemiologic identification of Leishmania strains R.F. Rocha 1 *, E.V. Menezes 1 *, A.R.E.O. Xavier 1 *, V.A. Royo 1, D.A. Oliveira 1, A.F.M. Júnior 1, E.S. Dias
More informationPOST KALA-AZAR DERMAL LEISHMANIASIS WITH ULCERATION ON FOOT: AN ATYPICAL CASE PRESENTATION SUCCESSFULLY TREATED WITH MILTEFOSINE
American Journal of Infectious Diseases 10 (2): 50-55, 2014 ISSN: 1553-6203 2014 Science Publication doi:10.3844/ajidsp.2014.50.55 Published Online 10 (2) 2014 (http://www.thescipub.com/ajid.toc) POST
More informationOral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Tropical Medicine and International Health doi:10.1111/tmi.12015 volume 18 no 1 pp 96 100 january 2013 Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial Shyam Sundar 1,
More informationNOTES. Th1/Th2 Cytokine Profile in Patients Coinfected with HIV and Leishmania in Brazil
CLINICAL AND VACCINE IMMUNOLOGY, Oct. 2011, p. 1765 1769 Vol. 18, No. 10 1556-6811/11/$12.00 doi:10.1128/cvi.00076-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. NOTES Th1/Th2
More informationAmoyDx TM BRAF V600E Mutation Detection Kit
AmoyDx TM BRAF V600E Mutation Detection Kit Detection of V600E mutation in the BRAF oncogene Instructions For Use Instructions Version: B3.1 Date of Revision: April 2012 Store at -20±2 o C 1/5 Background
More informationAntigen-triggered interferon-γ and interleukin-10 pattern in cured mucosal leishmaniasis patients is shaped during the active phase of disease
bs_bs_banner Clinical and Experimental Immunology ORIGINAL ARTICLE doi:1.1111/cei.12364 Antigen-triggered interferon-γ and interleukin-1 pattern in cured mucosal leishmaniasis patients is shaped during
More informationResearch Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis
ISRN Parasitology, Article ID 548010, 4 pages http://dx.doi.org/10.1155/2014/548010 Research Article Efficacy and Safety of Paromomycin in Treatment of Post-Kala-Azar Dermal Leishmaniasis Shyam Sundar,
More informationIsolation and identification of Mycoplasma gallisepticum in chickensbn from industrial farms in Kerman province
Available online at http://www.ijabbr.com International journal of Advanced Biological and Biomedical Research Volume 2, Issue 1, 2014: 100-104 Isolation and identification of Mycoplasma gallisepticum
More informationBRIEF COMMUNICATION ABSTRACT
BRIEF COMMUNICATION http://dx.doi.org/10.1590/s1678-9946201759048 Characterization of Leishmania (L.) infantum chagasi in visceral leishmaniasis associated with hiv co-infection in Northeastern Brazil
More informationINTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH Considerations
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH Considerations General Principles to Address Virus and Vector Shedding 1.0 Introduction
More informationCharacteristics of evaluation panel used for Round 2 of WHO malaria RDT product testing at U.S. CDC, 2009 WHO-FIND malaria RDT evaluation programme
(FIND) Special Programme for Research and Training in Tropical Diseases (TDR) Malaria ranch, Division of Parasitic Characteristics of evaluation panel used for Round 2 of WHO malaria RDT product testing
More informationMucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon
Universidade de São Paulo Biblioteca Digital da Produção Intelectual - BDPI Outros departamentos - FM/Outros Artigos e Materiais de Revistas Científicas - FM/Outros 2011 Mucosal Leishmaniasis Caused by
More informationTitle: Treatment failure and miltefosine susceptibility in dermal leishmaniasis
AAC Accepts, published online ahead of print on 21 October 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.01023-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Title:
More informationProtective and Pathologic T Cell Response in Cutaneous and Mucosal Leishmaniasis
Protective and Pathologic T Cell Response in Cutaneous and Mucosal Leishmaniasis EDGAR M. CARVALHO Serviço de Imunologia Hospital Universitário Prof. Edgard Santos Universidade Federal da Bahia Salvador-Bahia-Brazil
More informationResolution of an Infection with Leishmania braziliensis Confers Complete Protection to a Subsequent Challenge with Leishmania major in BALB/c Mice
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 94(1): 71-76, Jan./Feb. 1999 Resolution of an Infection with Leishmania braziliensis Confers Complete Protection to a Subsequent Challenge with Leishmania major
More informationNorgen s HIV proviral DNA PCR Kit was developed and validated to be used with the following PCR instruments: Qiagen Rotor-Gene Q BioRad icycler
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com HIV Proviral DNA PCR Kit Product # 33840 Product Insert Background Information
More informationDevelopment and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species
664 Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 107(5): 664-674, August 2012 Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite
More informationAssessment of Hyper Coagulabilty (activated partial thromboplastin time and prothrombin time) among Sudanese Patients with Schistosomiasis
EUROPEAN ACADEMIC RESEARCH Vol. IV, Issue 6/ September 2016 ISSN 2286-4822 www.euacademic.org Impact Factor: 3.4546 (UIF) DRJI Value: 5.9 (B+) Assessment of Hyper Coagulabilty (activated partial thromboplastin
More informationClinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation
ISPUB.COM The Internet Journal of Infectious Diseases Volume 6 Number 2 Clinical response to Highly Active Antiretroviral Treatment (HAART) in a patient with Kaposi's sarcoma: A case presentation Y Graza,
More informationT-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 102(5): 625-630, August 2007 625 T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia)
More informationLeishmaniasis: A forgotten disease among neglected people
ISPUB.COM The Internet Journal of Health Volume 11 Number 2 Leishmaniasis: A forgotten disease among neglected people Y Homsi, G Makdisi Citation Y Homsi, G Makdisi. Leishmaniasis: A forgotten disease
More informationThe feature of papers and citation analysis of eleven journals in tropical medicine indexed by Science Citation Index Expanded
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 100(7): 805-810, November 2005 805 The feature of papers and citation analysis of eleven journals in tropical medicine indexed by Science Citation Index Expanded
More informationDiagnosis of leprosy. Salvatore Noto and Pieter A M Schreuder
Diagnosis of leprosy 1 Contents Preface Part I. Introduction 1. Definition of leprosy 2. Leprosy a proteiform disease 3. How to put order in clinical leprosy 4. Tools available for the diagnosis of leprosy
More informationHIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis
Product Manual HIV-1 Genemer Detection Kit Ready to Use Amplification Kit for HIV-1 Specific DNA Fragment Analysis For research use only. Not for use in diagnostic procedures for clinical purposes Catalog
More information